|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.565 USD | +13.00% |
|
+25.34% | +240.74% |
| Market Cap | 288M 252M 232M 217M 409M 27.19B 418M 2.8B 1.08B 13.41B 1.08B 1.06B 46.57B | P/E 2026 * |
-2.12x | P/E 2027 * | -2.42x |
|---|---|---|---|---|---|
| Enterprise Value | 76.1M 66.63M 61.51M 57.44M 108M 7.19B 111M 740M 286M 3.55B 286M 279M 12.32B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 4.45x |
| Free-Float |
77.16% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Zentalis Pharmaceuticals, Inc.
| 1 day | +13.00% | ||
| 1 week | +25.34% | ||
| Current month | +15.00% | ||
| 1 month | +15.00% | ||
| 3 months | +114.95% | ||
| 6 months | +238.24% | ||
| Current year | +240.74% |
| 1 week | 3.6 |  | 4.88 |
| 1 month | 3.42 | | 4.88 |
| Current year | 1.32 | | 6.95 |
| 1 year | 1.13 | | 6.95 |
| 3 years | 1.01 | | 29.04 |
| 5 years | 1.01 | | 87.19 |
| 10 years | 1.01 | | 87.19 |
| Manager | Title | Age | Since |
|---|---|---|---|
Julia Eastland
CEO | Chief Executive Officer | 62 | 2024-11-12 |
| Director of Finance/CFO | - | 2024-11-12 | |
Ingmar Bruns
CTO | Chief Tech/Sci/R&D Officer | 51 | 2024-11-12 |
| Director | Title | Age | Since |
|---|---|---|---|
David Johnson
CHM | Chairman | 61 | 2022-05-15 |
Enoch Kariuki
BRD | Director/Board Member | 44 | 2021-02-08 |
Jan Skvarka
BRD | Director/Board Member | 59 | 2022-09-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-15 | Free | Chairman | 57,100 | 0.0802% | ||
| 06-15 | Free | Director | 57,100 | 0.0802% | ||
| 06-15 | Free | Director | 57,100 | 0.0802% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +13.00% | +25.34% | +296.55% | -83.65% | 288M | |
| +0.13% | -1.33% | +67.18% | +121.93% | 55.63B | |
| +6.76% | +22.83% | +91.66% | +101.42% | 52.25B | |
| +1.79% | +2.87% | -12.86% | -13.29% | 23.07B | |
| +0.79% | +5.64% | +3.51% | +412.65% | 22.41B | |
| +6.78% | +14.47% | +40.28% | -6.67% | 17.32B | |
| +0.97% | +3.81% | +30.68% | -32.21% | 15.94B | |
| -0.02% | +7.20% | +24.89% | +190.32% | 13.77B | |
| +9.96% | +19.81% | +157.65% | +320.70% | 13.47B | |
| +4.21% | +4.76% | +33.21% | - | 12.43B | |
| Average | +4.42% | +7.07% | +73.27% | +112.36% | 22.66B | |
| Weighted average by Cap. | +3.26% | +7.62% | +54.99% | +127.52% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 21.42M 18.75M 17.31M 16.17M 30.43M 2.02B 31.13M 208M 80.42M 999M 80.43M 78.66M 3.47B |
| Net income | -150M -131M -121M -113M -213M -14.19B -218M -1.46B -564M -7B -564M -551M -24.31B | -154M -135M -124M -116M -219M -14.55B -224M -1.5B -578M -7.18B -578M -565M -24.93B |
| Net Debt | -211M -185M -171M -160M -301M -20B -307M -2.06B -794M -9.86B -794M -777M -34.25B | -192M -168M -155M -145M -273M -18.17B -279M -1.87B -722M -8.96B -722M -706M -31.12B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-29 | US$4.600 | +13.86% | 1,758,454 |
| 26-06-26 | US$4.040 | +6.60% | 7,490,437 |
| 26-06-25 | US$3.790 | -4.53% | 937,553 |
| 26-06-24 | US$3.970 | +7.88% | 1,625,233 |
| 26-06-23 | US$3.680 | +0.27% | 674,398 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ZNTL Stock
Select your edition
All financial news and data tailored to specific country editions
